Current Edition

Editorial Archive

Should we Leave it to Patients to Identify Counterfeit Medicines?

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-V3I3-web-23.pdf
Continue Reading →
Editorial Archive

The EU Directive Against Falsified Medicines and the Role of Security Labels

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-V3I3-web-22.pdf
Continue Reading →
Editorial Archive

Shedding Enhanced Light on Biological and Biomedical Systems

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-V3I3-web-20.pdf
Continue Reading →
Editorial Archive

Safeguarding the Global Pharmaceutical Supply Chain

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-19.pdf
Continue Reading →
Editorial Archive

Safely Transporting Clinical Trials through the Middle East

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-18.pdf
Continue Reading →
Clinical Research v3i3

Modernising Subject Payments in Clinical Trials

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-17.pdf
Continue Reading →
Clinical Research v3i3

Managing the Use of Research- Grade Kits During Clinical Trials

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-16.pdf
Continue Reading →
Clinical Research v3i3

Feasibility, Risk Management and Clinical Trials – Art or Science?

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-15.pdf
Continue Reading →
Clinical Research v3i3

Optimising Clinical Research Site Performance through Additive Patient Enrolment

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-14.pdf
Continue Reading →